ADVM Stock Summary and Trading Ideas (Adverum Biotechnologies | NASDAQ:ADVM)

Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.

Adverum Biotechnologies trades on the NASDAQ stock market under the symbol ADVM.

As of December 12, 2025, ADVM stock price was flat at $4.36 with million shares trading.

ADVM has a beta of 0.93, meaning it tends to be less sensitive to market movements. ADVM has a correlation of 0.03 to the broad based SPY ETF.

ADVM has a market cap of $96.26 million. This is considered a Micro Cap stock.

Last quarter Adverum Biotechnologies reported $0 in Revenue and -$2.03 earnings per share. This fell short of revenue expectation by $-8 million and missed earnings estimates by -$1.48.

In the last 3 years, ADVM traded as high as $29.70 and as low as $1.78.

The top ETF exchange traded funds that ADVM belongs to (by Net Assets): VTI, VXF, MSSM.

ADVM has underperformed the market in the last year with a return of -23.8%, while SPY returned +14.0%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in ADVM shares. However, ADVM has outperformed the market in the last 3 month and 2 week periods, returning +44.4% and +5.8%, while SPY returned +4.0% and -0.2%, respectively. This indicates ADVM has been having a stronger performance recently.

ADVM support price is $4.30 and resistance is $4.42 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ADVM shares will trade within this expected range on the day.